AZN

AstraZeneca PLC (AZN)

Last Price$74.20.9%
Market Cap$460.2B
LTM Net Income
$7,035.0M
YoY Growth
+18.1%
3Y CAGR
+297.5%
5Y CAGR
+39.4%
Stock quality & Intrinsic value
7/10
60.2% overvalued

AstraZeneca PLC Net Income

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Net Income
$3,664.0M
$4,706.0M
$6,043.0M
$5,595.0M
$6,101.0M
$7,521.0M
$8,053.0M
$9,983.0M
$6,297.0M
$2,556.0M
$1,233.0M
$2,825.0M
$3,499.0M
$3,001.0M
$2,155.0M
$1,335.0M
$3,196.0M
$112.0M
$3,288.0M
$5,955.0M
AZN
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for AZN and see if it's the right time to invest.
Dive in

AstraZeneca PLC (AZN) Net Income comparison analysis

Crunching data... Almost there!

AZN key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is AstraZeneca PLC's Net Income?

As of today, AstraZeneca PLC's last 12-month Net Income is $7,035.0M, based on the financial report for Dec 31, 2024 (Q4 2024).

2) What is AstraZeneca PLC's Net Income growth rate?

Over the last year, AstraZeneca PLC's Net Income growth was 18.1%. The average annual Net Income growth rates for AstraZeneca PLC have been 23.1% over the past three years, 39.4% over the past five years.

3) Is AstraZeneca PLC's Net Income growth rate Good?

Over the last year, AstraZeneca PLC's Net Income growth was 18.1%, which is higher than industry growth of (0.2%). It indicates that AstraZeneca PLC's Net Income growth is Good.

4) How does AstraZeneca PLC's Net Income growth rate compare to its peers?

Over the last year, AstraZeneca PLC's Net Income growth was 18.1%, which is lower than peer median growth of 22.0%. The list of peers includes JNJ, MRK, NVS, LLY, PFE, SNY, ABBV, AMGN, GILD, BMY etc.